Helix
Helix is a population genomics company offering services like Exome+® sequencing to integrate genomic data into patient care.
Secondary Market Price
Secondary Market Price
How Helix Measures Up
To help you manage your Helix equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series C
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Helix's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Helix Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Helix's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Founded in 2015, Helix is a population genomics and precision health company headquartered in San Mateo, California. The company enables health systems, life sciences companies, and public health organizations to integrate genomic data into patient care, therapeutic development, and disease surveillance. Its offerings include next-generation sequencing, bioinformatics, proactive genetic screening, and the creation of large clinico-genomic datasets for research. Since its founding, Helix has developed a precision health network in North America and established expertise in exome sequencing and big data analysis.
The company's recent activities indicate a focus on expanding large-scale genomic studies and partnerships. Helix has collaborated with Rochester Regional Health to launch GenoWell, a no-cost genetic screening program, and partnered with Canada's University Health Network for the OurGenes Study, which will enroll up to 100,000 participants. The company also recently launched its GenoSphere™ MASH-enriched cohort, a dataset of over 17,000 clinico-genomic records for liver disease research. In 2025, Helix was named a finalist in the Fierce Innovation Awards in the Data Analytics/Business Intelligence category and was recognized by GenomeWeb as one of its Best Places to Work.
- Warburg Pincus
- DFJ Growth
- Kleiner Perkins Caufield Byers
- Mayo Clinic
- Temasek
- Illumina
- Sutter Hill Ventures
- LaunchCapital
- Casdin Capital
- National Institutes of Health (NIH)
- Co-Founder, James Lu
- Co-Founder, Justin Kao
- Co-Founder, Scott Burke
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Helix worth joining?
Deciding whether to join any startup depends on your personal career goals and risk tolerance. A key factor is the equity compensation, and you can use specialized platforms to model the potential future value of your stock options or RSUs.
What should I do with my Helix stock?
Managing private stock involves complex decisions around exercising options and selling shares to optimize your tax burden and financial outcome. Platforms like Prospect offer customized strategies and tax-optimization tools to help you navigate these choices.
Can you sell Helix stock?
As a private company, Helix shares can't be sold on a public exchange, but employees often have opportunities during company-run tender offers or on secondary markets. Tools designed for private equity can help you determine the best price and tax strategy for selling during these events.
How can I find the value of my Helix stock?
The value of private company stock is not public and is typically based on the company's most recent 409A valuation or the price set in a funding round. To better understand its potential, you can use platforms like Prospect which provide predictive models to help forecast your equity's future worth.
What is Helix's equity worth?
Because Helix is a private company, its total equity value is not publicly disclosed and changes with new funding rounds and business performance. You can, however, model your personal stake's potential value using scenario planning tools that account for different growth and exit outcomes.
What is Helix's stock ticker symbol?
Helix does not have a stock ticker symbol because it is a private company whose shares are not available on a public stock exchange. Ticker symbols are only assigned to companies once they complete an initial public offering (IPO).
Can I buy or sell Helix stock?
Buying shares in a private company like Helix is typically restricted to accredited investors during fundraising rounds, while selling is usually limited to company-approved liquidity events like tender offers. Platforms that specialize in private equity can help employees analyze their options and make informed decisions when opportunities to sell arise.
What is the criteria to buy or invest in Helix stock?
Investing in a private startup like Helix is generally restricted to accredited investors and venture capital firms participating in official financing rounds. Employees, on the other hand, typically receive equity as part of their compensation package rather than purchasing it directly.
